Back to RTW INVESTMENTS, LP RTW INVESTMENTS, LP

DYNDYN
8 quarters

Position history for RTW INVESTMENTS, LPRTW INVESTMENTS, LP's holdings in DYNE THERAPEUTICS INC

No. RTW Investments exited its DYN (Dyne Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 2,890,567 shares worth $36.6M. RTW Investments first reported DYN in Q1 2024 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$87.8M

Total Shares Change

-3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$19.20
0
2025-Q3
Increased
2.9M
+71.0%
$36.6M0.5%$12.37
52
2025-Q2
Unchanged
1.7M
0.0%
$16.1M0.2%$9.57
0
2025-Q1
Decreased
1.7M
-67.6%
$17.7M0.3%$11.45
0
2024-Q4
Decreased
5.2M
-23.5%
$123M1.9%$23.65
0
2024-Q3
Increased
6.8M
+6.8%
$244.9M3.5%$33.83
60
2024-Q2
Increased
6.4M
+106.6%
$225.4M3.5%$35.29
91
2024-Q1
New
3.1M
-
$87.8M1.3%$28.39
68

Other major holders of DYN: FMR LLC, BlackRock, Inc., Janus Henderson Group Ltd., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used